Free Trial

Crescent Biopharma (CBIO) Institutional Ownership

Crescent Biopharma logo
$22.02 +1.23 (+5.90%)
As of 02:44 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Crescent Biopharma (NASDAQ:CBIO)

Current
Institutional Ownership
Percentage
75.19%
Number of
Institutional Buyers
(last 12 months)
36
Total
Institutional Inflows
(last 12 months)
$181.61M
Number of
Institutional Sellers
(last 12 months)
8
Total
Institutional Outflows
(last 12 months)
$12.11M
Get CBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Crescent Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CBIO Institutional Buying and Selling by Quarter

Crescent Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE29,277$538K0.0%+425.3%0.106%
5/18/2026 ADAR1 Capital Management LLC50,273$924K0.1%-91.7%0.182%
5/18/2026 Exome Asset Management LLC153,191$2.81M1.5%N/A0.556%
5/15/2026 OMERS ADMINISTRATION Corp17,800$327K0.0%+53.4%0.065%
5/14/2026 Renaissance Technologies LLC24,262$446K0.0%-48.0%0.088%
5/6/2026 Jennison Associates LLC152,974$2.81M0.0%N/A0.555%
4/21/2026 Cannon Global Investment Management LLC10,200$187K0.4%N/A0.073%
2/18/2026 ADAR1 Capital Management LLC606,000$7.19M0.5%N/A4.362%
2/18/2026 Vestal Point Capital LP1,500,000$17.79M0.6%N/A10.797%
2/18/2026 Tang Capital Management LLC872,398$10.35M0.5%+28.3%6.279%
2/18/2026 Quadrature Capital Ltd13,246$157K0.0%N/A0.095%
2/18/2026 RTW Investments LP372,856$4.42M0.0%N/A2.684%
2/18/2026 Opaleye Management Inc.1,178,300$13.98M1.8%N/A8.483%
2/18/2026 Millennium Management LLC61,882$734K0.0%N/A0.446%
2/18/2026 Moore Capital Management LP25,000$296K0.0%N/A0.180%
2/18/2026 Balyasny Asset Management L.P.111,715$1.33M0.0%N/A0.804%
2/18/2026 BVF Inc. IL2,748,763$32.60M1.1%+98.1%19.790%
2/17/2026 ADAR1 Capital Management LLC606,000$7.19M0.5%N/A4.363%
2/17/2026 Burkehill Global Management LP74,000$844K0.1%N/A0.533%
2/17/2026 Heights Capital Management Inc.264,000$3.13M1.1%N/A1.901%
2/17/2026 Price T Rowe Associates Inc. MD338,125$4.01M0.0%-11.9%2.434%
2/17/2026 Fcpm Iii Services B.V.1,677,852$19.90M2.6%N/A12.080%
2/16/2026 OMERS ADMINISTRATION Corp11,600$138K0.0%N/A0.084%
2/16/2026 NEXTBio Capital Management LP372,856$4.42M2.6%N/A2.684%
2/13/2026 Marshall Wace LLP21,826$259K0.0%-50.0%0.157%
2/13/2026 Alyeska Investment Group L.P.264,000$3.11M0.0%N/A1.901%
2/13/2026 State Street Corp26,217$311K0.0%+40.8%0.189%
2/12/2026 Jane Street Group LLC22,965$272K0.0%N/A0.165%
2/12/2026 HRT Financial LP13,083$155K0.0%N/A0.094%
2/12/2026 Renaissance Technologies LLC46,700$554K0.0%+73.6%0.336%
2/10/2026 Goldman Sachs Group Inc.25,245$299K0.0%-31.7%0.182%
2/9/2026 Geode Capital Management LLC91,079$1.08M0.0%+31.7%0.656%
2/9/2026Jefferies Financial Group Inc.64,244$762K0.0%-37.5%0.462%
11/17/2025 Citadel Advisors LLC25,593$304K0.0%N/A0.184%
11/17/2025 Commodore Capital LP450,829$5.36M0.3%-0.6%3.245%
11/17/2025 Bank of America Corp DE3,863$46K0.0%-58.2%0.028%
11/14/2025 Two Sigma Investments LP28,318$337K0.0%N/A0.204%
11/13/2025Jefferies Financial Group Inc.102,714$1.22M0.0%+279.1%0.739%
11/7/2025Vanguard Group Inc.657,900$7.82M0.0%N/A3.365%
8/15/2025 Soleus Capital Management L.P.400,000$6.46M0.4%N/A2.046%
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
8/15/2025 Perceptive Advisors LLC453,686$7.32M0.7%N/A2.321%
8/15/2025 Frazier Life Sciences Management L.P.453,685$7.32M0.3%N/A2.321%
8/15/2025 Braidwell LP261,504$4.22M0.1%N/A1.338%
8/15/2025 BVF Inc. IL1,387,863$22.40M0.8%N/A7.099%
8/15/2025 Bank of America Corp DE9,231$149K0.0%N/A0.047%
8/15/2025 Adage Capital Partners GP L.L.C.100,912$1.63M0.0%N/A0.516%
8/14/2025 Commodore Capital LP453,686$7.32M0.5%N/A2.321%
8/13/2025 Affinity Asset Advisors LLC280,031$4.52M0.6%N/A1.432%
8/12/2025Jefferies Financial Group Inc.27,096$437K0.0%N/A0.139%
8/7/2023Acadian Asset Management LLC144,028$50K0.0%-44.5%0.381%
2/15/2023Nantahala Capital Management LLC438,055$231K0.0%-82.9%1.392%
11/10/2022Nantahala Capital Management LLC2,554,735$1.29M0.1%-7.3%8.116%
11/7/2022Virtu Financial LLC189,175$95K0.0%+250.5%0.601%
8/15/2022Nantahala Capital Management LLC2,755,903$4.91M0.2%+13.8%8.755%
8/13/2022Virtu Financial LLC53,977$96K0.0%N/A0.171%
2/8/2022Raymond James & Associates32,800$30K0.0%-74.7%0.104%


CBIO Institutional Ownership - Frequently Asked Questions

During the previous two years, 39 institutional investors and hedge funds held shares of Crescent Biopharma. The most heavily invested institutionals were BVF Inc. IL ($32.60M), Fcpm Iii Services B.V. ($19.90M), Vestal Point Capital LP ($17.79M), Opaleye Management Inc. ($13.98M), Tang Capital Management LLC ($10.35M), Vanguard Group Inc. ($7.82M), and Perceptive Advisors LLC ($7.32M).Learn more on Crescent Biopharma's institutional investors.

75.19% of Crescent Biopharma's stock is owned by institutional investors. Learn more on CBIO's institutional investor holdings.

Of the 36 institutional investors that purchased Crescent Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($2.75M), Fcpm Iii Services B.V. ($1.68M), Vestal Point Capital LP ($1.50M), ADAR1 Capital Management LLC ($1.21M), Opaleye Management Inc. ($1.18M), Vanguard Group Inc. ($657.90K), and Perceptive Advisors LLC ($453.69K).

Institutional investors have bought a total of 13,739,566 shares in the last 24 months. This purchase volume represents approximately $181.61M in transactions.

The following institutional investors have sold Crescent Biopharma stock in the last 24 months: ADAR1 Capital Management LLC ($555.73K), Price T Rowe Associates Inc. MD ($45.47K), Jefferies Financial Group Inc. ($38.47K), Renaissance Technologies LLC ($22.44K), Marshall Wace LLP ($21.87K), Goldman Sachs Group Inc. ($11.73K), and Bank of America Corp DE ($5.37K).

Institutional investors have sold a total of 703,928 shares in the last 24 months. This volume of shares sold represents approximately $12.11M in transactions.



This page (NASDAQ:CBIO) was last updated on 5/28/2026 by MarketBeat.com Staff.
From Our Partners